/PUMD

PUMD Stock - ProUroCare Medical Inc.

Q: What is the analyst price target for PUMD?

Analyst price target information is not currently available for PUMD.

Q: What is PUMD's market cap?

Market capitalization information is not currently available for PUMD.

Technology|Consumer Electronics|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Jan 12

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for PUMD

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2008

FY2009

FY2010

FY2011

FY2012

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-5.69

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2012	FY2011	FY2010	FY2009	FY2008
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-1,982,086	$-1,543,730	$-2,113,062	$-3,950,665	$-2,624,432
Net Income	$-2,959,145	$-2,063,212	$-6,019,380	$-6,944,064	$-4,657,717
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-0.17	$-0.13	$-0.44	$-0.73	$-2.65

Company Overview

ProUroCare Medical Inc. engages in developing products for the detection and characterization of male urological prostate disease. It offers the ProUroScan System, a prostate imaging system that aids the physician in documenting abnormalities in the prostate that have been previously detected by a digital rectal exam. The company has licensing, development, and commercialization agreements with Artann Laboratories Inc. for its ProUroScan System. ProUroCare Medical Inc. was founded in 1999 and is based in Eden Prairie, Minnesota.

Visit Website

Frequently Asked Questions about PUMD

What is PUMD's current stock price?

ProUroCare Medical Inc. (PUMD) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for PUMD?

No analyst price targets are currently available for this stock.

What sector is ProUroCare Medical Inc. in?

ProUroCare Medical Inc. operates in the Technology sector, specifically within the Consumer Electronics industry. The company is traded on the OTC exchange.

What is PUMD's market cap?

ProUroCare Medical Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does PUMD pay dividends?

No, ProUroCare Medical Inc. does not currently pay a dividend to shareholders.